Manufacturer of a wide range of products which include cresp 100 mg, darbepoetin alfa injection and cycloxan 1 g, cyclophosphamide injection ip, treatment : defferent kind of cancer.
₹ 5650 / Box Get Latest Price
| Strength | 100 mcg |
| Brand | Cresp 100 mg |
| Composition | Darbepoetin Alfa |
| Treatment | Anemia due to chronic kidney disease |
| Form | Injection |
| Country of Origin | Made in India |
| Dosage | 100 mg |
Minimum order quantity: 1 Box
₹ 160 / Vial Get Latest Price
| Strength | 1 g |
| Form | Injection |
| Brand | Cycloxan |
| Packaging type | Box |
| Storage Condition | cool and dry place away from sunlight |
| Composition | CYCLOPHOSPHAMIDE-1GM |
| Dosage | 1 g |
| Country of Origin | Made in India |
| Manufacturer | BIOCHEM PHARMACEUTICAL INDUSTRIES |
| Treatment | Malignant diseases (cancer),nephrotic syndrome (kidney disease) |
Minimum order quantity: 10 Vial
Cyclophosphamide Injection IP 1g Cycloxan 1 g
PRODUCT DETAILS
About CYCLOXAN INJECTION 1GM
CYCLOXAN INJECTION 1GM belongs to the group of medicines called alkylating agents used to treat malignant diseases such as Hodgkin's disease, mixed-cell type lymphoma, lymphocytic lymphoma, histiocytic lymphoma, multiple myeloma, Burkitt's lymphoma, leukaemia, neuroblastoma, retinoblastoma, adenocarcinoma of the ovary, mycosis fungoides, Ewing's sarcoma, small cell lung cancer, advanced/metastatic neuroblastoma and breast carcinoma. Additionally, CYCLOXAN INJECTION 1GM is used to treat minimal change nephrotic syndrome (kidney disease) in paediatric patients.
CYCLOXAN INJECTION 1GM contains 'Cyclophosphamide' that works by stopping or slowing the growth of cancer cells in the body. Thereby, CYCLOXAN INJECTION 1GM helps treat cancer. CYCLOXAN INJECTION 1GM suppresses the body's immune system and helps treat nephrotic syndrome.
In some cases, CYCLOXAN INJECTION 1GM may cause nausea, vomiting, stomatitis (inflamed and sore mouth), weakness, malaise (general discomfort), fever, leukopenia (low white blood cell count), and alopecia (hair loss). You are advised to talk to your doctor if the side effects persist or worsen.
Uses of CYCLOXAN INJECTION 1GM
Malignant diseases (cancer), nephrotic syndrome (kidney disease)
Medicinal Benefits
CYCLOXAN INJECTION 1GM belongs to the group of medicines called alkylating agents used to treat malignant diseases such as Hodgkin's disease (cancer of the lymphatic system), mixed-cell type lymphoma, lymphocytic lymphoma, histiocytic lymphoma, multiple myeloma (cancer of plasma cells), Burkitt's lymphoma, leukaemia (blood cancer), neuroblastoma (cancer commonly found in the adrenal glands), retinoblastoma (eye cancer), adenocarcinoma of the ovary, mycosis fungoides, Ewing's sarcoma (cancer in and around the bones), small cell lung cancer, advanced/metastatic neuroblastoma and breast carcinoma. CYCLOXAN INJECTION 1GM works by stopping or slowing the growth of cancer cells in the body. Thereby, CYCLOXAN INJECTION 1GM helps treat cancer. Additionally, CYCLOXAN INJECTION 1GM is used to treat minimal change nephrotic syndrome (kidney disease) in paediatric patients. CYCLOXAN INJECTION 1GM suppresses the body's immune system, thereby helping treat nephrotic syndrome.
Directions for Use
CYCLOXAN INJECTION 1GM will be administered by a healthcare professional; do not self-administer.
Storage
Store in a cool and dry place away from sunlight
Side Effects of CYCLOXAN INJECTION 1GM
Nausea
Vomiting
Stomatitis (inflamed and sore mouth)
Weakness
Malaise (general discomfort)
Fever
Leukopenia (low white blood cell count)
Alopecia (hair loss)
Habit Forming
No
Diet & Lifestyle Advise
Eat a healthy diet and exercise regularly to maintain proper weight.
Avoid smoking and alcohol consumption.
Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, herbs, and spices in your food.
Avoid fast food, fried food, processed meats, refined carbs and added sugar.
Get optimal sleep; rest well.
Special Advise
Monitoring of complete blood count whilst on treatment with CYCLOXAN INJECTION 1GM is advised.
Women of childbearing potential must use highly effective contraception during treatment and for up to 1 year after the last dose.
Male patients who are sexually active with a female partner of child-bearing potential must use condoms during treatment and for up to 6 months after the last dose.
Dipesh Kakadiya (Owner)
Corsantrum Technology
1st Floor, Office No. 114, Katargam, Mahek Icon
Surat - 395008, Gujarat, India